Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Rosa Klotz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4123-261X; OpenAlex author ID A5025421446. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers · 2026: 2 papers

Papers 14

  1. Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006407↗
  2. Surgery in Oligometastatic Pancreatic Cancer: Narrative Systematic Review. First author DOI 10.3390/cancers18111699↗
  3. ChatGPT vs. surgeons on pancreatic cancer queries: accuracy & empathy evaluated by patients and experts. Co-author DOI 10.1016/j.hpb.2024.11.012↗
  4. Radical antegrade modular pancreatosplenectomy versus conventional left pancreatectomy for pancreatic cancer: study protocol for the multicentre randomized cli… Co-author DOI 10.1093/bjsopen/zraf169↗
  5. Erratum: The real-world management of advanced pancreatic cancer in China. Co-author DOI 10.1097/jp9.0000000000000220↗
  6. [Sex differences in pancreatic cancer]. Last author DOI 10.1007/s00104-024-02150-6↗
  7. Intraoperative end-tidal carbon dioxide levels are not associated with recurrence-free survival after elective pancreatic cancer surgery: a retrospective cohor… Co-author DOI 10.3389/fmed.2024.1442283↗
  8. Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers15061815↗
  9. Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2022.2027148↗
  10. Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis. Co-author DOI 10.1093/bjsopen/zrac010↗
  11. Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma. First author DOI 10.3389/fimmu.2022.947407↗
  12. Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic… Co-author DOI 10.1080/2162402x.2021.1962135↗
  13. Langerhans islets induce anti-tumor immunity at the expense of glycemic control and predict chemotherapy response in pancreatic cancer Co-author DOI 10.1101/2021.03.13.435100↗
  14. Top ten research priorities for pancreatic cancer therapy. Co-author DOI 10.1016/s1470-2045(20)30179-0↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thilo Hackert · 9 shared papers, 2020–2026 · strength 1.53
  2. Azaz Ahmed · 8 shared papers, 2020–2025 · strength 1.37
  3. Christoph W. Michalski · 5 shared papers, 2024–2025 · strength 1.36
  4. Martin Loos · 4 shared papers, 2024–2026 · strength 0.96
  5. Markus Wolfgang Büchler · 4 shared papers, 2022–2026 · strength 0.83
  6. Dirk Jäger · 5 shared papers, 2021–2023 · strength 0.74
  7. Nathalia A. Giese · 5 shared papers, 2021–2023 · strength 0.74
  8. Niels Halama · 5 shared papers, 2021–2023 · strength 0.74
  9. Christoph Springfeld · 5 shared papers, 2021–2023 · strength 0.74
  10. Magdalena Holze · 2 shared papers, 2024–2025 · strength 0.48
  11. Mohammed Al‐Saeedi · 2 shared papers, 2025–2026 · strength 0.45
  12. Frank Pianka · 2 shared papers, 2025–2026 · strength 0.45
  13. Bo Kong · 1 shared paper, 2025 · strength 0.42
  14. Thomas P. Hank · 2 shared papers, 2022–2026 · strength 0.41
  15. Oliver Strobel · 2 shared papers, 2022–2026 · strength 0.41
  16. Christoph Michalski · 1 shared paper, 2026 · strength 0.39
  17. Artur Rebelo · 1 shared paper, 2026 · strength 0.39
  18. Ulrich Ronellenfitsch · 1 shared paper, 2026 · strength 0.39
  19. Jorg H. Kleeff · 1 shared paper, 2026 · strength 0.39
  20. Markus K. Diener · 2 shared papers, 2020–2025 · strength 0.32
  21. Martin A. Schneider · 1 shared paper, 2026 · strength 0.24
  22. Benedict Kinny‐Köster · 1 shared paper, 2026 · strength 0.24
  23. Thomas Moritz Pausch · 1 shared paper, 2025 · strength 0.23
  24. Susanne Roth · 1 shared paper, 2025 · strength 0.23
  25. Jörg Kaiser · 1 shared paper, 2025 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.